123 related articles for article (PubMed ID: 10086640)
1. The impact of open access 24-h pH-metry on the diagnosis and management of esophageal reflux disease.
Eckardt VF; Dilling B; Bernhard G
Am J Gastroenterol; 1999 Mar; 94(3):616-21. PubMed ID: 10086640
[TBL] [Abstract][Full Text] [Related]
2. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.
López-Alonso M; Moya MJ; Cabo JA; Ribas J; del Carmen Macías M; Silny J; Sifrim D
Pediatrics; 2006 Aug; 118(2):e299-308. PubMed ID: 16831894
[TBL] [Abstract][Full Text] [Related]
3. [Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD)].
Mönkemüller K; Neumann H; Fry LC; Kolfenbach S; Malfertheiner P
Z Gastroenterol; 2009 Apr; 47(4):351-6. PubMed ID: 19358061
[TBL] [Abstract][Full Text] [Related]
4. Is esophageal pH monitoring used appropriately in an open-access system? A prospective multicenter study.
Radaelli F; Strocchi E; Passaretti S; Strada E; Frego R; Dinelli M; Fossati D; Barzaghi F; Limido E; Bortoli A; Della Casa D; Missale G; Snider L; Noris R; Viviani G; Minoli G
Am J Gastroenterol; 2004 Nov; 99(11):2115-20. PubMed ID: 15554989
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and clinical relevance of proximal esophageal pH monitoring.
Cool M; Poelmans J; Feenstra L; Tack J
Am J Gastroenterol; 2004 Dec; 99(12):2317-23. PubMed ID: 15571576
[TBL] [Abstract][Full Text] [Related]
6. Non-erosive and erosive gastroesophageal reflux diseases: No difference with regard to reflux pattern and motility abnormalities.
Martínek J; Benes M; Hucl T; Drastich P; Stirand P; Spicák J
Scand J Gastroenterol; 2008; 43(7):794-800. PubMed ID: 18584517
[TBL] [Abstract][Full Text] [Related]
7. [Perception of symptoms with minimal reductions of esophageal pH in patients with erosive and non-erosive GERD].
Remes-Troche JM; Gómez-Escudero O; Ruíz JC; Schmulson MJ; Valdovinos Díaz MA
Rev Gastroenterol Mex; 2004; 69(1):30-6. PubMed ID: 15193061
[TBL] [Abstract][Full Text] [Related]
8. Role of manometry and pH-metry in patients with symptoms and signs of gastroesophageal reflux disease.
Bresadola V; Dado G; Terrosu G; Alessandrini V; Marcellino MG; Bresadola F
Chir Ital; 2003; 55(6):785-90. PubMed ID: 14725217
[TBL] [Abstract][Full Text] [Related]
9. Ambulatory 24-hour pH-metry in the diagnosis of gastroesophageal reflux disease. Determination of criteria and relation to endoscopy.
Masclee AA; de Best AC; de Graaf R; Cluysenaer OJ; Jansen JB
Scand J Gastroenterol; 1990 Mar; 25(3):225-30. PubMed ID: 2181620
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic augmentation of the lower esophageal sphincter for the treatment of gastroesophageal reflux disease: multicenter study of the Gatekeeper Reflux Repair System.
Fockens P; Bruno MJ; Gabbrielli A; Odegaard S; Hatlebakk J; Allescher HD; Rösch T; Rhodes M; Bastid C; Rey J; Boyer J; Muehldorffer S; van den Hombergh U; Costamagna G
Endoscopy; 2004 Aug; 36(8):682-9. PubMed ID: 15280972
[TBL] [Abstract][Full Text] [Related]
11. [Non-erosive gastroesophageal reflux disease. Incidence of clinical forms, characteristics of esophageal exposure to acid and symptomatic correlations].
Soto Pérez JC; Icaza ME; Vargas F; Valdovinos Díaz MA
Rev Gastroenterol Mex; 2003; 68(2):113-9. PubMed ID: 15127647
[TBL] [Abstract][Full Text] [Related]
12. Selective use of esophageal manometry and 24-Hour pH monitoring before laparoscopic fundoplication.
Frantzides CT; Carlson MA; Madan AK; Stewart ET; Smith C
J Am Coll Surg; 2003 Sep; 197(3):358-63; discussion 363-4. PubMed ID: 12946787
[TBL] [Abstract][Full Text] [Related]
13. Impact of 24-h esophageal pH monitoring on the diagnosis of gastroesophageal reflux disease: defining the gold standard.
Madan K; Ahuja V; Gupta SD; Bal C; Kapoor A; Sharma MP
J Gastroenterol Hepatol; 2005 Jan; 20(1):30-7. PubMed ID: 15610443
[TBL] [Abstract][Full Text] [Related]
14. Relationship of severity of gastroesophageal reflux disease with gastric acid secretory profile and esophageal acid exposure during nocturnal acid breakthrough: a study using 24-h dual-channel pH-metry.
Ghoshal UC; Chourasia D; Tripathi S; Misra A; Singh K
Scand J Gastroenterol; 2008; 43(6):654-61. PubMed ID: 18569981
[TBL] [Abstract][Full Text] [Related]
15. [Intestinal metaplasia at the esophagogastric junction. Prevelence and association in patients undergoing endoscopy].
Castro ML; Fachal C; Pineda JR; Domínguez F; Prada JI; Hermo JA; Suso J; Clofent J
Gastroenterol Hepatol; 2002 Oct; 25(8):487-92. PubMed ID: 12361529
[TBL] [Abstract][Full Text] [Related]
16. Esophageal dysmotility as an important co-factor in extraesophageal manifestations of gastroesophageal reflux.
Knight RE; Wells JR; Parrish RS
Laryngoscope; 2000 Sep; 110(9):1462-6. PubMed ID: 10983943
[TBL] [Abstract][Full Text] [Related]
17. Gastro-esophageal reflux and esophageal motility disorders in morbidly obese patients.
Suter M; Dorta G; Giusti V; Calmes JM
Obes Surg; 2004 Aug; 14(7):959-66. PubMed ID: 15329186
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of gastroesophageal reflux disease in institutionalized intellectually disabled individuals.
Böhmer CJ; Niezen-de Boer MC; Klinkenberg-Knol EC; Devillé WL; Nadorp JH; Meuwissen SG
Am J Gastroenterol; 1999 Mar; 94(3):804-10. PubMed ID: 10086670
[TBL] [Abstract][Full Text] [Related]
19. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers.
Shay S; Tutuian R; Sifrim D; Vela M; Wise J; Balaji N; Zhang X; Adhami T; Murray J; Peters J; Castell D
Am J Gastroenterol; 2004 Jun; 99(6):1037-43. PubMed ID: 15180722
[TBL] [Abstract][Full Text] [Related]
20. [Reflux esophagitis: manometry and Ph measurement].
Eberl T; Wienbeck M; Barnert J
Praxis (Bern 1994); 1996 Nov; 85(45):1428-31. PubMed ID: 8975351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
